Feature Reviews in Cell Death

Dear Colleagues,

This Special Issue aims to present a comprehensive collection of state-of-the art reviews exploring the multifaced mechanism of cell death and its implication in different diseases and therapies. The latest advancements in the field are welcomed, debating molecular pathways governing apoptosis, necrosis, or autophagy and the intricate roles of cell death in development, disease, and therapy. We encourage scientists to submit their papers on in-depth analysis of novel biomarkers, cutting-edge techniques, and emerging therapeutic strategies targeting cell death pathways. By integrating diverse perspectives and innovative research, this collection will serve as a valuable resource for scientists and clinicians seeking to understand cell death and how to manipulate it for improved health outcomes.

Aims and scope

This Special Issue highlights the importance of cell death studies in the context of personalized medicine, precision oncology, and regenerative medicine. By elucidating the complex interplay between cell death and disease states, this collection aims to provide a platform for researchers to exchange ideas, share their latest findings and collaborate on innovative approaches to harnessing the power of cell death for therapeutic purposes.

We welcome contributions that address the challenges and opportunities in translating basic research on cell death into clinical applications, thereby identifying potential novel druggable targets and developing new strategies for personalized treatments.

This Special Issue will be a comprehensive resource for researchers, clinicians, and industry professionals interested in advancing our understanding of cell death and its implication in human health. We look forward to receiving high-quality submissions that will contribute to the growing body of knowledge on this crucial biological process and its therapeutic potential.

This collection aims to include only review papers: comprehensive reviews, systematic reviews, and literature reviews.

Dr. Adrian-Bogdan Țigu
Dr. Madalina Nistor
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cell death pathways
• apoptosis
• necrosis
• biomarkers
• therapies